Tracy Beth Høeg, a top lieutenant to Food and Drug Administration Commissioner Marty Makary, will be the next leader of the Center for Drug Evaluation and Research.

Changes to the ways in which the FDA plans to regulate vaccines represent a threat to effective vaccines and public health, 12 former commissioners say.

The move comes a day after Richard Pazdur, a top FDA official and Michele’s boss, announced his decision to retire.

A topical hair loss medication successfully built up hair in a Phase 3 trial, according to the results of two late-stage trials released Wednesday.

Why are so many primary care doctors are switching between two Harvard-affiliated hospital systems?

In this AI Prognosis newsletter: Are the benefits of AI scribes immeasurable, or are we just measuring them wrong?

Richard Pazdur, the FDA's top drug regulator, has filed papers to retire at the end of this month, adding to the turmoil at the agency

And more biotech news updates, brought to you by The Readout

Bristol Myers Squibb will enroll more patients in a key Phase 3 trial studying its drug Cobenfy in psychosis associated with Alzheimer's disease.

And other health news from the Morning Rounds newsletter